-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Depression is a common mental disorder.
Depression is a common mental disorder.
The global incidence of Lancet depression is about 6%, and the lifetime risk is 15-18%, which means that 1 in 5 people has experienced depression at some point in their lives.
Due to the high incidence of depression, multiple professional guidelines and certification agencies recommend depression screening for cancer patients , as well as more extensive screening for young and middle-aged women.
Screening PHQ-9 is a validated, widely used, short questionnaire, mainly used to assess depression symptoms and identify individuals at risk of depression.
diagnosis
Screening for depressive symptoms is especially important for high-risk groups, including young breast cancer survivors (YBCS).
Breast Cancer Breast cancer is the most common cancer in young women (<50 years old), and they account for approximately 19% of the incidence of breast cancer.
If the score of the first two PHQ-9 items (range=0-6) is ≥3 points, it meets the criteria for major depressive disorder (MDD).
A total of 231 women met the pre-qualification criteria for the study of mild depressive symptoms and participated in the study.
At baseline, 22.
Assess depression, anxiety, self-harming thoughts and treatments
Assess depression, anxiety, self-harming thoughts and treatmentsIn summary, depression symptoms have nothing to do with demographic characteristics or cancer treatment history, which suggests that depression screening is necessary for breast cancer patients.
In summary, depression symptoms have nothing to do with demographic characteristics or cancer treatment history, which suggests that depression screening is necessary for breast cancer patients.
references:
Screening for Depression in Younger Breast Cancer Survivors: Outcomes From Use of the 9-item Patient Health Questionnaire, JNCI Cancer Spectrum , Volume 5, Issue 3, June 2021, pkab017, https://doi.
Screening for Depression in Younger Breast Cancer Survivors : Outcomes From Use of the 9-item Patient Health Questionnaire, JNCI Cancer Spectrum
in this message
